Your browser doesn't support javascript.
loading
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
Man, Kenneth K C; Häge, Alexander; Banaschewski, Tobias; Inglis, Sarah K; Buitelaar, Jan; Carucci, Sara; Danckaerts, Marina; Dittmann, Ralf W; Falissard, Bruno; Garas, Peter; Hollis, Chris; Konrad, Kerstin; Kovshoff, Hanna; Liddle, Elizabeth; McCarthy, Suzanne; Neubert, Antje; Nagy, Peter; Rosenthal, Eric; Sonuga-Barke, Edmund J S; Zuddas, Alessandro; Wong, Ian C K; Coghill, David.
Affiliation
  • Man KKC; Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK; Centre for Medicines Optimisation Research and Education, University College London Hospitals NHS Foundation Trust, London, UK; Centre for Safe Medication Practice and Research, Department of Pharm
  • Häge A; Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
  • Banaschewski T; Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
  • Inglis SK; Tayside Clinical Trials Unit, University of Dundee, Dundee, UK.
  • Buitelaar J; Radboudumc, Donders Institute for Brain, Cognition and Behavior, Department of Cognitive Neuroscience, Nijmegen, Netherlands; Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, Netherlands.
  • Carucci S; Division of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy; Child and Adolescent Neuropsychiatry Unit, A Cao Paediatric Hospital, Cagliari, Italy.
  • Danckaerts M; Department of Neurosciences, Developmental Psychiatry, KU Leuven, Leuven, Belgium; Department of Child and Adolescent Psychiatry, University Psychiatric Center KU Leuven, Leuven, Belgium.
  • Dittmann RW; Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
  • Falissard B; Centre de Recherche en Epidemiologie et Santé des Populations, CESP, INSERM U1018, Université Paris-Saclay, Paris, France.
  • Garas P; Mental Health Sciences, Schools of PhD Studies, Semmelweis University, Budapest, Hungary.
  • Hollis C; NIHR Nottingham Biomedical Research Centre, School of Medicine, University of Nottingham, Nottingham, UK; NIHR MindTech MedTech Co-operative, School of Medicine, University of Nottingham, Nottingham, UK; Institute of Mental Health, and Mental Health and Clinical Neurosciences, School of Medicine, Un
  • Konrad K; Child Neuropsychology Section, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital RWTH Aachen, Aachen, Germany; JARA-Brain Institute II, Molecular Neuroscience and Neuroimaging, RWTH Aachen and Research Centre Jülich, Jülich, Germany.
  • Kovshoff H; School of Psychology, University of Southampton, Southampton, UK.
  • Liddle E; Centre for ADHD and Neurodevelopmental Disorders Across the Lifespan, University of Nottingham, Nottingham, UK.
  • McCarthy S; School of Pharmacy, University College Cork, Cork, Ireland.
  • Neubert A; Department of Paediatrics and Adolescents Medicine, Universitätsklinikum Erlangen, Erlangen, Germany.
  • Nagy P; Vadaskert Child and Adolescent Psychiatric Hospital, Budapest, Hungary; Division of Neurodevelopmental Disorders, Bethesda Children's Hospital, Budapest, Hungary.
  • Rosenthal E; Evelina London Children's Hospital, London, UK.
  • Sonuga-Barke EJS; School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Zuddas A; Child and Adolescent Neuropsychiatry Unit, Department of Biomedical Sciences, University of Cagliari and A Cao Paediatric Hospital, G Brotzu Hospital Trust, Cagliari, Italy.
  • Wong ICK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong Special Administrative Region, China; Aston Pharmacy School, Aston University, Birmingham, UK.
  • Coghill D; Departments of Paediatrics and Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia; Murdoch Children's Research Institute, Melbourne, VIC, Australia; Faculty of Medicine, University of Dundee, Dundee, UK. Electronic address: david.coghil
Lancet Psychiatry ; 10(5): 323-333, 2023 05.
Article in En | MEDLINE | ID: mdl-36958362
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Central Nervous System Stimulants / Methylphenidate Type of study: Clinical_trials Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Lancet Psychiatry Year: 2023 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Central Nervous System Stimulants / Methylphenidate Type of study: Clinical_trials Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Lancet Psychiatry Year: 2023 Document type: Article Country of publication: United kingdom